← Leaderboards
Eicke Latz
Univ Of Massachusetts Med Sch Worcester
$5,911,104
Attributed
$9,795,391
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2009–20$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,795,391 · 4
By mechanism
R01$9,795,391 · 4
Top collaborators
- Michael Leo Fitzgerald9 shared
- Katherine A Fitzgerald5 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Katherine A Fitzgerald$21,686,859
- Gyongyi Szabo$43,043,172
- Peter Whittaker$400,242
- Khanh-Van Thi Tran$1,481,929
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineCellsMediatingLeadInflammatorySignal TransductionMolecularBaseIn VitroInfectionIn VivoInflammationPreventCleaved CellLow-Density LipoproteinsLipidsImmuneInterleukin-12Mouse ModelArterial Fatty StreakMacrophageCholesterolCrystallizationAtherosclerosis
Grant awards (19)
Epigenetic Reprogramming in Atherosclerosis$673,647
R01 · FY2020 · HL · contact PI
Epigenetic Reprogramming in Atherosclerosis$673,647
R01 · FY2019 · HL · contact PI
Epigenetic Reprogramming in Atherosclerosis$673,647
R01 · FY2018 · HL · contact PI
Epigenetic Reprogramming in Atherosclerosis$690,522
R01 · FY2017 · HL · contact PI
HDL prevention of cholesterol crystal inflammation in HIV disease$605,847
R01 · FY2016 · HL
HDL prevention of cholesterol crystal inflammation in HIV disease$602,921
R01 · FY2015 · HL
HDL prevention of cholesterol crystal inflammation in HIV disease$605,998
R01 · FY2014 · HL
HDL prevention of cholesterol crystal inflammation in HIV disease$593,424
R01 · FY2013 · HL
Inflammasome activation by cholesterol crystals$387,595
R01 · FY2013 · HL · contact PI
Role of PISA; a PYHIN Family Member in Intracellular DNA Recognition$378,883
R01 · FY2013 · AI
HDL prevention of cholesterol crystal inflammation in HIV disease$646,768
R01 · FY2012 · HL
Inflammasome activation by cholesterol crystals$407,138
R01 · FY2012 · HL · contact PI
Role of PISA; a PYHIN Family Member in Intracellular DNA Recognition$403,066
R01 · FY2012 · AI
Inflammasome activation by cholesterol crystals$411,250
R01 · FY2011 · HL · contact PI
Role of PISA; a PYHIN Family Member in Intracellular DNA Recognition$403,066
R01 · FY2011 · AI
Inflammasome activation by cholesterol crystals$411,042
R01 · FY2010 · HL · contact PI
Role of PISA; a PYHIN Family Member in Intracellular DNA Recognition$407,138
R01 · FY2010 · AI
Role of PISA; a PYHIN Family Member in Intracellular DNA Recognition$410,000
R01 · FY2009 · AI · contact PI
Inflammasome activation by cholesterol crystals$409,792
R01 · FY2009 · HL · contact PI